Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Vaccines

Free Subscription Articles published in AIDS Retrieve available abstracts of 16 articles: HTML format Text format

Single Articles

April 2018
1. GEORGE VK, Pallikkuth S, Pahwa R, de Armas L, et al
   Circulating inflammatory monocytes contribute to impaired influenza vaccine responses in HIV-infected participants.
   AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001821.
   PubMed     Text format     Abstract available
   
   
   March 2018
2. ISMAIL MF, Wong DK, Bogoch II
   The role for hepatitis A vaccination in HIV pre-exposure prophylaxis.
   AIDS. 2018;32:675-676.
   PubMed     Text format    
   
   
   February 2018
3. FARFOUR E, Lesprit P, Wai ACH, Mazaux L, et al
   Acute hepatitis A breakthrough in MSM in Paris area: implementation of targeted hepatitis A virus vaccine in a context of vaccine shortage.
   AIDS. 2018;32:531-532.
   PubMed     Text format    
   
   
   
4. PALLIKKUTH S, De Armas LR, Pahwa R, Rinaldi S, et al
   Impact of aging and HIV infection on serologic response to seasonal influenza vaccination.
   AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001774.
   PubMed     Text format     Abstract available
   
   
   
5. WEINBERG A, Huang S, Moscicki AB, Saah A, et al
   Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children.
   AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001773.
   PubMed     Text format     Abstract available
   
   
   December 2016
6. HARPER KN
   New mouse models provide insights into how to design a more effective HIV vaccine.
   AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001371.
   PubMed     Text format    
   
   
   November 2016
7. YOUNAS M, Carrat F, Finge S, Desaint C, et al
   Immune activation, smoking, and vaccine response.
   AIDS. 2016.
   PubMed     Text format     Abstract available
   
   
   
8. SELVA KJ, Kent SJ, Parsons MS
   Modulation of innate and adaptive cellular immunity relevant to HIV-1 vaccine design by seminal plasma.
   AIDS. 2016.
   PubMed     Text format     Abstract available
   
   
   October 2016
9. HARPER KN
   HVTN100 Phase 1/2 Vaccine Trial Results Promising; Phase 2b/3 Trial to Commence.
   AIDS. 2016.
   PubMed     Text format    
   
   
   September 2016
10. GUARDO AC, Joe PT, Miralles L, Bargallo ME, et al
    Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix).
    AIDS. 2016.
    PubMed     Text format     Abstract available
    
    
    
11. LEVIN MJ, Lindsey JC, Kaplan SS, Schimana W, et al
    Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.
    AIDS. 2016.
    PubMed     Text format     Abstract available
    
    
    August 2016
12. EMMER KL, Wieczorek L, Tuyishime S, Molnar S, et al
    Antibody responses to prime-boost vaccination with an HIV-1 gp145 Env protein and chimpanzee adenovirus vectors expressing HIV-1 gp140.
    AIDS. 2016.
    PubMed     Text format     Abstract available
    
    
    July 2016
13. CHIODI F
    Pneumococcal vaccination of HIV-infected young adults is an important global priority.
    AIDS. 2016;30:1991-3.
    PubMed     Text format    
    
    
    
14. YEK C, Gianella S, Plana M, Castro P, et al
    Standard vaccines increase HIV-1 transcription during antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available
    
    
    
15. PARK SY, Mack WJ, Lee HY
    Enhancement of viral escape in HIV-1 Nef by STEP vaccination.
    AIDS. 2016.
    PubMed     Text format     Abstract available
    
    
    
16. VOSS JE, Macauley MS, Rogers KA, Villinger F, et al
    Reproducing SIVDeltanef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front lines.
    AIDS. 2016.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: